Rbamylated proteins may possibly serve as beneficial quantitative biomarkers of timeaveraged urea concentrations while also providing risk assessment in sufferers with kidney disease. Additionally, the hyperlink in between carbamylated proteins and illness pathophysiology creates an enticing therapeutic target for decreasing the rate of carbamylation. This article evaluations the biochemistry of t